Overview
Kimio Tohyama practices practicing medicine in Fujisawa, Japan.
Their clinical expertise encompasses Nonalcoholic Steatohepatitis (NASH).
They are actively involved in clinical research, co-authoring 32 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kimio Tohyama
Is Kimio Tohyama a top-rated expert for Nonalcoholic Steatohepatitis (NASH)?
MediFind is an objective health platform that identifies experts based on real-world data. Kimio Tohyama is classified as an Experienced expert for Nonalcoholic Steatohepatitis (NASH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kimio Tohyama participate in research or clinical trials?
Yes. Kimio Tohyama has published 32 articles and abstracts on conditions like Nonalcoholic Steatohepatitis (NASH). You can view a list of Kimio Tohyama's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Nonalcoholic Steatohepatitis (NASH)